Advertisement

Topics

DRUG FACTS | Triadine Prep

12:44 EDT 24th July 2014 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Povidone Iodine,10% w/v (equivalent to 1% titratable iodine)

Antiseptic

For external use only.

If swallowed, get medical help or contact a Poison Control Center right away.

Cat. No. 10-8204NDC 50730-8204-4 TRIADINE™

POVIDONE-IODINE, USP PREP SOLUTION 10% Topical Solution ANTISEPTIC / GERMICIDE

For External Use Only! 4 Fluid Ounces (118 ml)

www.triad-group.net

TRIAD GROUP, INC.700 West North Shore DriveHartland, WI 53029 MADE IN USA

Manufacturer

Triad Group

Active Ingredients

Source

Clinical Trials [132 Associated Clinical Trials listed on BioPortfolio]

Advanced HIV Prevention (PrEP Chicago)

This study will evaluate the feasibility of a network intervention to train individuals to disseminate PrEP information and motivate initial PrEP interest and knowledge of PrEP in their so...

PrEP for HBCUs (Study 2)

The investigators' overall goals are to target (a) pre-exposure prophylaxis (PrEP) uptake by addressing access and acceptability and (b) PrEP adherence among Historically Black Colleges an...

Pepped on Pre-exposure Prophylaxis (PrEP): A Counseling and Problem-Solving PrEP Adherence Intervention for Stimulant Using Men Who Have Sex With Men (MSM).

Pepped on PrEP is an innovative pilot RCT designed by an interdisciplinary team to develop a counseling and problem-solving PrEP adherence intervention with a Behavioral Activation (BA) ap...

PrEP Implementation for Mothers in Antenatal Care

In a region with 15-20% HIV prevalence, an estimated 20% of HIV-uninfected women could have HIV exposures in pregnancy. In a theoretical scenario of perfect PrEP coverage, all women at ris...

A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production

A safety study to compare the effect of two different formulations of PrEP-001 nasal powder when dosed in healthy subjects

PubMed Articles [91 Associated PubMed Articles listed on BioPortfolio]

An Experimental Investigation of Implicit Hiv And Prep Stigma: Evidence For Ancillary Benefits of Prep Use.

PrEP stigma (i.e., negative attitudes toward PrEP users) has been widely documented and is considered a significant barrier to implementation. However, few studies have examined PrEP stigma using impl...

Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention.

Pre-exposure prophylaxis (PrEP) can reduce U.S. HIV incidence. We assessed insurance coverage and its association with PrEP utilization. We reviewed patient data at three PrEP clinics (Jackson, Missis...

PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships.

PrEP is efficacious for African women at risk for HIV, but data on adherence outside of clinical trials are sparse. We describe the persistence and execution of PrEP use among women participating in a...

"Support Your Client at the Space That They're in": HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-Related Risk Compensation.

Despite the demonstrated effectiveness of HIV pre-exposure prophylaxis (PrEP) and evidence that most PrEP users do not engage in risk compensation (i.e., increased risk behavior due to a perceived dec...

Stigma, Partners, Providers and Costs: Potential Barriers to PrEP Uptake among US Women.

Pre-Exposure Prophylaxis (PrEP) use has remained low among US women while significantly increasing among men who have sex with men. Besides lack of awareness, women face several social and structural ...

Quick Search
Advertisement
 

Drugs and Medication Quicklinks


Searches Linking to this Drug Record